Elanco Animal Health Incorporated ELAN
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 18.00M | 54.00M | 57.00M | -276.00M | -34.00M |
| Total Depreciation and Amortization | 171.00M | 165.00M | 166.00M | 168.00M | 168.00M |
| Total Amortization of Deferred Charges | 6.00M | 6.00M | 6.00M | 6.00M | 8.00M |
| Total Other Non-Cash Items | 52.00M | 28.00M | 47.00M | -15.00M | 18.00M |
| Change in Net Operating Assets | -31.00M | 24.00M | -263.00M | 225.00M | 59.00M |
| Cash from Operations | 216.00M | 277.00M | 13.00M | 108.00M | 219.00M |
| Capital Expenditure | -60.00M | -33.00M | -51.00M | -62.00M | -92.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | -76.00M | -- | -- | -- |
| Divestitures | -- | -- | -- | 0.00 | 0.00 |
| Other Investing Activities | -2.00M | -1.00M | -9.00M | -2.00M | -9.00M |
| Cash from Investing | -62.00M | -110.00M | -60.00M | -64.00M | -101.00M |
| Total Debt Issued | 0.00 | 50.00M | -- | 2.11B | 290.00M |
| Total Debt Repaid | -215.00M | -123.00M | -16.00M | -2.11B | -188.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -1.00M | -1.00M | -34.00M | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -15.00M | -17.00M | -255.00M |
| Cash from Financing | -216.00M | -74.00M | -65.00M | -18.00M | -153.00M |
| Foreign Exchange rate Adjustments | -3.00M | 9.00M | -5.00M | 14.00M | 1.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -65.00M | 102.00M | -117.00M | 40.00M | -34.00M |